RecallDepth
Class III Terminated

Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4 blisters per carton (NDC 0093-5509-44), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.

Company
Teva Pharmaceuticals Usa
Recall Initiated
February 17, 2017
Posted
March 15, 2017
Recall Number
D-0511-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
25,916 cartons
Firm Location
North Wales, PA, United States

Reason for Recall

Failed Dissolution Specifications: low out of specification dissolution results found during stability testing.

Distribution

Nationwide in the United States and Puerto Rico

Lot / Code Info

Lot # 34025762A, Exp 06/17

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class III Drug recalls